Webinar | Biologics Manufacturing Innovation for Medicine Supply Security
November 15, 2023
Virtual
Join Us November 15, 2023 @ 11:00 AM EST
Nick Hutchinson, Business Steering Group Leader for Mammalian Cell Culture, FUJIFILM Diosynth Biotechnologies is presenting on Biologics Manufacturing Innovation for Medicine Supply Security
- Global patient demand for biological medicines continues to grow driven by an increasing burden of cancers, infectious disease, immunological and neurological disorders. The World Economic Forum reports medicine supply challenges are being faced around the world leading to medicine shortages. Companies manufacturing biologics must have resilient supply chains that can be adapted to circumstances such as meeting the needs of niche markets, addressing the threat of pandemics, and controlling the costs of new medicines.
- FUJIFILM Diosynth Biotechnologies is fostering trusting partnerships with clients by executing its strategy of building a global network of modular-designed large-scale and single-use facilities through an aligned production platform. This will allow customers to ramp up production rapidly and transfer processes at unprecedented speed. To support clients further we have developed an innovative single-use continuous biomanufacturing platform providing even more agility and with the potential to improve product quality while reducing medicine production costs.